USE OF DRUG PATTERN IN SYMPTOMATIC ATRIOVENTRICULAR BLOCK IN CARDIAC PATIENTS AT SHAHID GANGALAL NATIONAL HEART CENTER

Authors

  • YAIMAN SIDDIQUE Valley College of Technical Sciences, Purvanchal University, Kathmandu, Nepal
  • SANJEEV GURUNG Valley College of Technical Sciences, Purvanchal University, Kathmandu, Nepal
  • HEMANK KC Valley College of Technical Sciences, Purvanchal University, Kathmandu, Nepal
  • SUNITA ADHIKARI Valley College of Technical Sciences, Purvanchal University, Kathmandu, Nepal
  • ANISHA KHATRI Valley College of Technical Sciences, Purvanchal University, Kathmandu, Nepal.
  • AKASH RAI Valley College of Technical Sciences, Purvanchal University, Kathmandu, Nepal

DOI:

https://doi.org/10.22159/ijms.2024v12i5.51713

Keywords:

Beta-blockers, Digoxin, Amiodarone, Calcium channel blockers, Atrioventricular block, Conduction disorder

Abstract

Objectives: Some of the medications which are used for the treatment of cardiovascular disease sometimes can impair the atrioventricular (AV) conduction, resulting in AV block. We aim to study the use of drug pattern in symptomatic AV block in cardiac patients

 Methods: A quantitative study method and retrospective observational research design were used; the selected study area was Shahid Gangalal National Heart Centre, Bansbari, Kathmandu. The secondary data were collected, that is, past medical records of 384 patients who were admitted to the hospital with the diagnosis of second, third, and high-degree AV block from February 2020 to July 2023. The total duration of the study was 6 months. We analyze the demographic, co-morbidities, and electrocardiography characteristics and also the use of drug pattern in AV block. The descriptive inference was used to analyze the data.

Results and Discussion: Most of the patients with symptomatic AV block were from the age group above 70 years. Of 384 patients, 187 (48.7%) received calcium channel blockers (CCBs), followed by 36 (9.4%), 10 (2.6%), 5 (1.3%), and 377 (98.2%) received beta-blockers, digoxin, amiodarone, and with/without other medications, respectively, where 3.9% had drug-induced AV block which was resolved after a change in medication along with other supportive measures.

Conclusion: CCBs, beta-blockers, digoxin, and amiodarone along with/without other medication are mostly used medications in patients who have AV block and AV block is rarely caused by drugs.

References

Bhatt YK. The deadly epidemic of cardiovascular disease. Nepal Heart J 2000;1:1-2.

Shrestha M, Pyakurel P, Yadav KP, Singh S, Priyadarshini S, Rajak B, et al. Knowledge, attitude and practices regarding cardiovascular diseases among people of Pakhribas municipalty of Eastern Nepal. Nepal Heart J 2020;17:33-9.

Reddy KK, Rao AP, Reddy TP. Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pac J Clin Nutr 2002;11:98-103.

Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel PK. Prevalence of other associated risk factors of cardiovascular disease among hypertensive patients in Eastern Nepal. Nepal Heart J 2014;11:27-31.

Shareef M, Bahadur MK, Raut R, Hirachan A, Bishal KC, Agarwal AK, et al. Etiology of heart failure in the emergency department of a tertiary cardiac centre of Nepal. Nepal Heart J 2017;14:1-4.

Bhattarai M, Shah RK, Sainju NK, Bhandari B, Keshari S, Karki DB. Etiological spectrum of heart failure in a tertiary health care facility of Central Nepal. Nepal Heart J 2019;16:23-8.

Chaurasia BD, Garg K. Human Anatomy: Regional and Applied Dissection and Clinical. 5th ed. New Delhi, India: CBS Publishers and Distributors; 2010.

Kashou AH, Goyal A, Nguyen T, Chhabra L. Atrioventricular block. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Available from: http://www.ncbi.nlm.nih.gov/books/NBK459147 [Last accessed on 2023 Jan 21].

Jain AK. Text Book of Physiology. 4th ed., Vol. 1. Sirmour, Himachal Pradesh: Avichal Publishing Company; 2011. p. 301-3.

Miller JM. Heart Disease. 1.6 ed. Philadelphia, PA: Saunders; 2001. p. 1086.

Sauer W. Etiology of Atrioventricular Block. Available from: https:// www.medilib.ir/uptodate/show/907 [Last accessed on 2023 Jan 21].

Shrestha RK, Khan GM, Thapa P, Koju R. Study of the side effects profile of different antihypertensive drugs among the hypertensive patient. Nepal Heart J 2013;9:25-9.

Marcu DT, Adam CA, Dorobanțu DM, Șalaru DL, Sascău RA, Balasanian MO, et al. Beta-blocker-related atrioventricular conduction disorders-a single tertiary referral center experience. Medicina (Kaunas) 2022;58:320.

Bhattarai SP, Neupane P. Knowledge and practices on prevention of coronary artery diseases in Nepalese community: A cross-sectional from five different cities in Nepal. Nepal Heart J 2018;15:33-6.

Adhikari S, Gajurel RM, Poudel CM, Shrestha H, Thapa S, Devkota S, et al. Precipitating factors leading to decompensation of heart failure in patients attending a tertiary care centre of Nepal. Nepal Heart J 2020;17:17-21.

Zeltser D, Justo D, Halkin A, Rosso R, Ish Shalom M, Hochenberg M, et al. Drug-Induced Atrioventricular Block: Prognosis after Discontinuation of the Culprit Drug. Elsevier Enhanced Reader; 2004. Available from: https://reader.elsevier.com [Last accessed on 2023 Jan 21].

Published

01-09-2024

How to Cite

YAIMAN SIDDIQUE, SANJEEV GURUNG, HEMANK KC, SUNITA ADHIKARI, ANISHA KHATRI, & AKASH RAI. (2024). USE OF DRUG PATTERN IN SYMPTOMATIC ATRIOVENTRICULAR BLOCK IN CARDIAC PATIENTS AT SHAHID GANGALAL NATIONAL HEART CENTER. Innovare Journal of Medical Sciences, 12(5), 1–4. https://doi.org/10.22159/ijms.2024v12i5.51713

Issue

Section

Original Article(s)